June 6, 2017 / 12:16 PM / 6 months ago

BRIEF-NantKwest expands nant cancer vaccine program

June 6 (Reuters) - Nantkwest Inc:

* NantKwest expands nant cancer vaccine program with additional clinical trials announced addressing multiple cancer types across all stages of disease

* NantKwest Inc - expansion of company’s existing nant cancer vaccine program in pancreatic cancer to target a number of additional tumor types

* NantKwest - first combination off shelf NK, adaptive immunotherapy trial to be initiated for pancreatic, lung, breast and colon cancer, among others Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below